HighTower Advisors’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$252K 3485
2022
Q2
$252K Hold
25,000
﹤0.01% 2479
2022
Q1
$251K Hold
25,000
﹤0.01% 2660
2021
Q4
$249K Buy
+25,000
New +$249K ﹤0.01% 2600

Other funds holding DTRT

HighTower Advisors's DTRT Position: Q3 2022 in Review

HighTower Advisors sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q3 2022, closing a stake of 25,000 shares — an estimated $252K sold.

HighTower Advisors first reported a position in DTRT in Q4 2021 and held it in 3 quarters. The position peaked at $252K in Q2 2022. 58 funds tracked by Wall St. Rank hold DTRT as of Q3 2022.

  • HighTower Advisors reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • HighTower Advisors sold 25,000 DTRT Health Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $252K.
  • HighTower Advisors first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • HighTower Advisors's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $252K in Q2 2022.
  • 58 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on HighTower Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.